Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
about
APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.Functional deprivation promotes amyloid plaque pathogenesis in Tg2576 mouse olfactory bulb and piriform cortex.Global analysis of S-nitrosylation sites in the wild type (APP) transgenic mouse brain-clues for synaptic pathology.The impact of human and mouse differences in NOS2 gene expression on the brain's redox and immune environment.Neuroprotective strategies involving ROS in Alzheimer disease.NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.Hypertension and cognitive functionProtection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.Strategies for molecular imaging dementia and neurodegenerative diseases.The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP.The role of intracellular zinc release in aging, oxidative stress, and Alzheimer's disease.Overexpression of neprilysin reduces alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, anHigh sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease.A high calorie diet causes memory loss, metabolic syndrome and oxidative stress into hippocampus and temporal cortex of rats.Sildenafil Improves Vascular and Metabolic Function in Patients with Alzheimer's Disease.Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice.Microsphere embolism-induced endothelial nitric oxide synthase expression mediates disruption of the blood-brain barrier in rat brain.Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products.Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice.
P2860
Q30455082-FEBFCCF9-3F35-4E25-ABCC-192886CD4110Q30623665-D8FE725B-48A9-4831-9863-485838FC651AQ33818653-903F0415-EB4A-4BCE-8A9D-FB8C1E5E5326Q34157658-5AE9A4FF-69EF-4651-A3BF-A0ACB63E0F1FQ34584761-098EB326-ED83-4D4D-BCA1-40AA0F32945EQ34757939-C9EC7330-21C1-4A7A-8219-7794EF11FF1DQ34998995-9C87A3D1-F7E8-40E7-A2C8-F9203DD0D9FFQ35178724-D6BE565D-C78E-467B-A6D3-E7FBAACD89A3Q36403694-8DA629C1-ADB7-4EC4-96A2-2FC10CC7E846Q36853915-865C403C-33E9-48DF-A732-06228E483CB6Q37354744-31077357-F899-4B35-951D-EB924D88BBB2Q38214602-0C592637-3348-42E2-A803-0CBC35658C7EQ39627415-E9C478E6-AC26-43FC-A012-69B5E6483403Q43184305-3D69F6B2-D640-41DB-ADAF-11211DCD4B8EQ46715012-79CC46E2-6D95-4CE7-899E-8FF40912FE86Q47784347-7214163E-8F43-45F8-865B-D971F57FFB65Q48383246-91C79A79-32E0-42E7-ADC3-04D2F69C9E6BQ48417456-9A264CC6-82AA-43BC-A025-BE3A1472EB10Q50578085-21999A07-0C63-47FB-A8E1-B1AAE33C9F59Q53432778-E250F0A6-A47F-4497-B56B-E6BCEA866354
P2860
Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Nitric oxide in the cerebral c ...... n (SW) Tg2576 transgenic mice.
@en
Nitric oxide in the cerebral cortex of amyloid-precursor protein
@nl
type
label
Nitric oxide in the cerebral c ...... n (SW) Tg2576 transgenic mice.
@en
Nitric oxide in the cerebral cortex of amyloid-precursor protein
@nl
prefLabel
Nitric oxide in the cerebral c ...... n (SW) Tg2576 transgenic mice.
@en
Nitric oxide in the cerebral cortex of amyloid-precursor protein
@nl
P2093
P1433
P1476
Nitric oxide in the cerebral c ...... n (SW) Tg2576 transgenic mice.
@en
P2093
Bentura ML
Castro-Blanco S
Fernández AP
Fernández-Vizarra P
Gómez-Isla T
Martínez-Murillo R
P356
10.1016/J.NEUROSCIENCE.2004.06.030
P407
P50
P577
2004-01-01T00:00:00Z